Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

TIPS: a reality in Brazil.

D'Albuquerque LA, Carnevale FC.

Arq Gastroenterol. 2012 Apr-Jun;49(2):97-8. No abstract available.

2.

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M.

Clin Liver Dis. 2012 Feb;16(1):133-46. doi: 10.1016/j.cld.2011.12.008. Epub 2012 Jan 4. Review.

PMID:
22321469
3.

Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.

Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D.

J Gastroenterol Hepatol. 2011 Jun;26(6):943-51. doi: 10.1111/j.1440-1746.2011.06663.x. Review.

PMID:
21251067
4.

Re: Management of TIPS-related refractory hepatic encephalopathy with reduced wallgraft endoprostheses.

Haskal ZJ.

J Vasc Interv Radiol. 2004 Aug;15(8):885; author reply 885-6. No abstract available.

PMID:
15318403
5.

Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.

Biecker E, Hausdörfer I, Grünhage F, Strunk H, Sauerbruch T.

Digestion. 2011;83(1-2):24-31. doi: 10.1159/000288522. Epub 2010 Sep 16.

PMID:
20847560
6.

Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft.

Riggio O, Nicolao F, Angeloni S, Masini A, Salvatori F, Fanelli F, Efrati C, Merli M.

Scand J Gastroenterol. 2003 May;38(5):570-2. No abstract available.

PMID:
12795474
7.

Can an incomplete stent expansion modulate the effects of TIPS?

Riggio O, Angeloni S, Ridola L, Rossi P.

J Gastroenterol. 2010 Mar;45(3):346-7; author reply 348. doi: 10.1007/s00535-009-0175-y. Epub 2010 Jan 5. No abstract available.

PMID:
20047121
8.

MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

Krieger S, Jauss M, Jansen O, Stiehl A, Sauer P, Geissler M, Theilmann L, Krieger D.

J Hepatol. 1997 Jul;27(1):121-6.

PMID:
9252084
9.

Prevention of first overt episode of hepatic encephalopathy after TIPS: no easy task.

Mullen KD, Ghanta RK, Putka BS.

Hepatology. 2006 May;43(5):1155-6. No abstract available.

PMID:
16628645
10.

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.

Nolte W, Wiltfang J, Schindler C, Münke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G.

Hepatology. 1998 Nov;28(5):1215-25.

PMID:
9794904
11.

Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Weitzman G, Schamberg NJ, Lake-Bakaar G.

Dig Dis Sci. 2007 Nov;52(11):3270-4. Epub 2007 Jul 20. No abstract available.

PMID:
17638078
12.

Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy.

Rössle M, Piotraschke J.

Dig Dis. 1996;14 Suppl 1:12-9. Review.

PMID:
8872448
14.

Hepatic encephalopathy: you should only comment on what you have actually measured.

Montagnese S, Schiff S, Gatta A, Riggio O, Morgan MY, Amodio P.

J Gastroenterol. 2010 Mar;45(3):342-3; author reply 344-5. doi: 10.1007/s00535-009-0171-2. Epub 2009 Dec 10. No abstract available.

PMID:
19997943
15.

[TIPS--transjugular intrahepatic portosystemic shunt. Experiences from a recently started center].

Astrup LB, Grønbaek H, Redsted S, Nielsen DT, Vilstrup H.

Ugeskr Laeger. 2003 Jan 27;165(5):443-6. Danish.

PMID:
12599839
16.

Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.

Iversen P, Keiding S, Mouridsen K, Ott P, Vilstrup H.

Clin Gastroenterol Hepatol. 2011 Nov;9(11):1001-3. doi: 10.1016/j.cgh.2011.07.015. Epub 2011 Jul 30.

PMID:
21806953
17.

Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M.

Am J Gastroenterol. 2008 Nov;103(11):2738-46. doi: 10.1111/j.1572-0241.2008.02102.x. Epub 2008 Sep 4.

PMID:
18775022
18.

A modified procedure for transjugular intrahepatic portosystemic shunt flow reduction.

Jacquier A, Vidal V, Monnet O, Varoquaux A, Gaubert JY, Champsaur P, Gerolami R, Bartoli JM, Moulin G.

J Vasc Interv Radiol. 2006 Aug;17(8):1359-63.

PMID:
16923985
19.

[Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].

Martínez Moreno B, Bellot P, de España F, Palazón JM, Such J, Pérez-Mateo M.

Gastroenterol Hepatol. 2011 Aug-Sep;34(7):468-73. doi: 10.1016/j.gastrohep.2011.03.021. Epub 2011 Jun 8. Spanish.

PMID:
21652116
20.

Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation.

Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Häussinger D.

Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1383-94. doi: 10.1097/MEG.0b013e328310e0c3.

PMID:
19738480

Supplemental Content

Support Center